2016 Clinical Publications on EECP/ECP

[ecpforum]

1. Effects of enhanced external counterpulsation on skeletal muscle gene expression in patients with severe heart failure. Melin M, Montelius A, Rydén L, Gonon A, Hagerman I, Rullman E. Clin Physiol Funct Imaging. 2016 Oct 26. doi: 10.1111/cpf.12392. PMID: 27782354
2. Enhanced External Counterpulsation Therapy: Past, Present, and Future. Raza A, Steinberg K, Tartaglia J, Frishman WH, Gupta T. Cardiol Rev. 2017 Mar/Apr;25(2):59-67. doi: 10.1097/CRD.0000000000000122. Review. PMID: 27548685
3. Enhanced external counterpulsation (EECP) decreases advanced glycation end products and proinflammatory cytokines in patients with non-insulin-dependent type II diabetes mellitus for up to 6 months following treatment. Sardina PD, Martin JS, Dzieza WK, Braith RW. Acta Diabetol. 2016 Oct;53(5):753-60. doi: 10.1007/s00592-016-0869-6. Epub 2016 Jun 9. PMID: 27278477
4. Increases in Cardiac Output and Oxygen Consumption During Enhanced External Counterpulsation. Ahlbom M, Hagerman I, Ståhlberg M, Manouras A, Förstedt G, Wu E, Lund LH. Heart Lung Circ. 2016 Nov;25(11):1133-1136. doi: 10.1016/j.hlc.2016.04.013. Epub 2016 May 18. PMID: 27267480
5. Enhanced external counterpulsation (EECP) improves biomarkers of glycemic control in patients with non-insulin-dependent type II diabetes mellitus for up to 3 months following treatment. Sardina PD, Martin JS, Avery JC, Braith RW. Acta Diabetol. 2016 Oct;53(5):745-52. doi: 10.1007/s00592-016-0866-9. Epub 2016 May 14. PMID: 27179825
6. Does Enhanced External Counterpulsation (EECP) Significantly Affect Myocardial Perfusion?: A Systematic Review & Meta-Analysis. Qin X, Deng Y, Wu D, Yu L, Huang R.PLoS One. 2016 Apr 5;11(4):e0151822. doi: 10.1371/journal.pone.0151822. eCollection 2016. Review. PMID: 27045935 Free PMC Article